|
The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- NAHL Group PLC - Kettering, UK-base consumer marketing services provider focused on the legal services sector - Announces interim results for the first six months of 2024. Says revenue decreases 7.4% annually to £19.4 million from £21.0 million, ‘as previously guided’. Attributes this to ‘a [20%] reduction in revenues from the personal injury business in what was a challenging and unusually competitive market’. In the Consumer Legal Services division, which includes personal injury, revenue fell 17% to £11.4 million. Operating profit was flat at £1.8 million. NAHL swung to £501,000 pretax profit, ‘almost as high as for the whole of the previous year’, from a £43,000 loss. Remains ‘confident in delivering a full year outturn in line with market expectations’. Adds that it is negotiating with select potential buyers of its critical care business Bush & Co, and hopes to conclude discussions before the end of this year. ---------- Metals One PLC - operator of strategic minerals projects in Norway and Finland - Pretax loss widens to £773,505 in first half of 2024 from £118,893 the previous year. Generates no revenue, unchanged. Administrative costs have surged to £700,064 from £118,893. Says it is rapidly advancing the Black Schist project in Finland towards commercialisation, and that ongoing preliminary economic investment work commissioned in August will support its application for EU Strategic Project status. Expects this if granted to ‘open up development funding and permit fast-tracking opportunities’. Chair Alastair Clayton says: ‘Together, our projects represent an opportunity...to become a key supplier of strategic minerals to European OEMs which are in growing need of traceable, sustainable supplies and are incentivised by supportive EU legislation to seek local sources of critical metals.’ ---------- Globalworth Real Estate Investments Ltd - Central and Eastern Europe-focused real estate investor - Pretax loss for first half of 2024 widens to €65.1 million from €44.3 million in 2023. Includes €24.1 million loss on disposal of subsidiary, up from €164,000 the year before. Revenue rises 5.0% to €125.0 million from €119.1 million. Dividend for the period decreases 27% to 11 euro cents from 15 cents. Cites increase in hybrid working as a factor in rental rates going up. Says however that previous headwinds have begun to dissipate; that inflation is increasingly under control with interest rates falling; and that it is benefitting from a healthy supply and demand balance. ---------- N4 Pharma PLC - Derbyshire, England-based pharmaceutical company focused on the development of nanoparticle technology Nuvec - Pretax loss for first half of 2024 narrows to £491,705 on-year from £646,150. Generates £3,906 in revenue, up from no revenue in 2023. General & administrative costs decrease 16% to £379,924 from £452,276. Says it is ‘now in a position to focus some of our resources on the development of products with clearly addressable and potentially material markets, these initially being IBD and glaucoma’. Notes that period included ‘meaningful progress’ in developing Nuvec as a therapeutic delivery system, with prospect of ‘two exciting lead products’ - one using Nuvec in treating gastrointestinal disorders, with the other using Liptide in prevention of scarring after glaucoma surgery. ---------- Copyright 2024 Alliance News Ltd. All Rights Reserved.
|
